Explore how immunosuppressive therapy impacts the gut microbiome of kidney transplant recipients and the differences between everolimus- and tacrolimus-based regimens.
Exploring how gut microbiota-derived metabolites influence outcomes in allogeneic hematopoietic cell transplantation and graft-versus-host disease.
Exploring how biomarkers in the SER-155 trial predict outcomes for transplant patients through microbiome therapeutics
Exploring the impact of VRE colonization on allogeneic hematopoietic cell transplantation outcomes and survival rates.